Polygenic risk scores estimate genetic predisposition to complex diseases by combining thousands of DNA variants. Dr. Anna CF Lewis of Harvard Medical School discusses their promise for personalized ...

Using genomics, evolutionary biologists test several hypotheses on the origin of viruses. New evidence suggests they may have ...

A new genomic method has enabled multiple people with rare conditions to receive diagnoses that were previously unattainable ...

As we look ahead in 2025, the pace of discovery in genetics continues to accelerate, marking the third decade of the 21st century with remarkable ...

Cathie Wood's ARK Invest bought $3M in DraftKings stock and $5M in genomics stocks on Oct 29. Full breakdown of ARK's latest trades and portfolio moves.

The rapid expansion of genomic technologies has transformed oncology, enabling comprehensive profiling of tumor DNA at unprecedented scale. Yet, the ...

Castle Biosciences (NASDAQ:CSTL) advances molecular diagnostics for cancer care. Strengthens clinical presence in dermatologic and genomic testing. Expanding research underscores leadership in ...

The biopharmaceutical industry demands rapid, accurate and regulatory-compliant testing to ensure product quality and process efficiency. However, traditional analytical methods often lack the speed ...

Financial literacy for the Primary School level has taken a new high with the launch of a financial literacy E-book by the Central Bank of Belize in partnership with the Ministry of Education. Today, ...

10X Genomics Inc. sued Illumina Inc., accusing it of infringing patents covering single-cell genetic sequencing and spatial technology. Illumina’s products and systems infringe a total of nine patents ...

The MarketWatch News Department was not involved in the creation of this content. IRVINE, Calif., Oct. 21, 2025 /PRNewswire/ -- Breakthrough Genomics, a leader in AI-powered clinical genomics ...

[SINGAPORE] Life sciences player Illumina is set to grow its 1,700-strong headcount in Singapore by around 20 to 25 per cent over the next five years. Illumina chief financial officer Ankur Dhingra ...